Targeted IL-12 Treatments and Methods to Stimulate haNK and NK92mi Cells
US-2024360191-A1 · Oct 31, 2024 · US
Mcfarlane Heather is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mcfarlane Heather |
| Total patents | 13 |
| First publication | Mar 29, 2018 |
| Latest publication | Oct 31, 2024 |
Publications ranked by popularity score, then publication date.
US-2024360191-A1 · Oct 31, 2024 · US
US-12098177-B2 · Sep 24, 2024 · US
US-2024124598-A1 · Apr 18, 2024 · US
US-11814436-B2 · Nov 14, 2023 · US
US-2022289805-A1 · Sep 15, 2022 · US
US-2022275098-A1 · Sep 1, 2022 · US
US-2021061871-A1 · Mar 4, 2021 · US
US-10736884-B2 · Aug 11, 2020 · US
US-2020069654-A1 · Mar 5, 2020 · US
US-10525040-B2 · Jan 7, 2020 · US
Latest publications not already listed above.
US-10487078-B2 · Nov 26, 2019 · US
US-2018185335-A1 · Jul 5, 2018 · US
US-2018086752-A1 · Mar 29, 2018 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Nantbio Inc | 12 |
| Nantomics Llc | 5 |
| Nant Holdings Ip Llc | 5 |
| Nantbioscience Inc | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 10 |
| C07K2317/622 | 7 |
| C07K2319/33 | 7 |
| A61K40/15 | 6 |
| A61K45/06 | 5 |